Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -11.56% is 54% below its 5-year average of -7.50%, near the low end of its 5-year range (-14.75%–2.39%).
As of the fiscal period ended Tuesday, June 30, 2026. 2.88% above its 12-month average of -11.90%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -11.56%.
RETURN ON EQUITY (ROE)
-11.56%
RETURN ON EQUITY (ROE) AVG TTM
-11.90%
RETURN ON EQUITY (ROE) AVG 3Y
-8.73%
RETURN ON EQUITY (ROE) AVG 5Y
-7.50%
RETURN ON EQUITY (ROE) AVG 10Y
-9.35%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+2.88%
CURRENT VS 3Y AVG
-32.44%
CURRENT VS 5Y AVG
-54.11%
CURRENT VS 10Y AVG
-23.70%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.20%
median of 653 covered companies
CURRENT VS SECTOR MEDIAN
+71.24%
vs the sector median at left
OrthoPediatrics Corp.
Market Cap
$589.15M
Return on Equity (ROE)
-11.56%
TTM Avg
-11.90%
3Y Avg
-8.73%
5Y Avg
-7.50%
Market Cap
$588.32M
Return on Equity (ROE)
-8.42%
TTM Avg
-4.61%
3Y Avg
-3.17%
5Y Avg
11.46%
Market Cap
$599.19M
Return on Equity (ROE)
N/A
TTM Avg
-4.73%
3Y Avg
76.70%
5Y Avg
93.92%
Market Cap
$604.49M
Return on Equity (ROE)
-21.51%
TTM Avg
-20.05%
3Y Avg
-35.91%
5Y Avg
-26.18%
Market Cap
$574.01M
Return on Equity (ROE)
N/A
TTM Avg
161.13%
3Y Avg
93.89%
5Y Avg
96.07%
Market Cap
$566.43M
Return on Equity (ROE)
40.62%
TTM Avg
9.52%
3Y Avg
-25.24%
5Y Avg
-32.61%
Market Cap
$562.76M
Return on Equity (ROE)
-26.37%
TTM Avg
-3503.18%
3Y Avg
-1722.33%
5Y Avg
3198.08%
Market Cap
$560.00M
Return on Equity (ROE)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$627.65M
Return on Equity (ROE)
-471.98%
TTM Avg
-147.16%
3Y Avg
-120.43%
5Y Avg
-93.49%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OrthoPediatrics Corp. (KIDS) | $589.15M | -11.56% | -11.90% | -8.73% | -7.50% |
| Fulgent Genetics, Inc. (FLGT)vs › | $588.32M | -8.42% | -4.61% | -3.17% | 11.46% |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $599.19M | N/A | -4.73% | 76.70% | 93.92% |
| AngioDynamics, Inc. (ANGO)vs › | $604.49M | -21.51% | -20.05% | -35.91% | -26.18% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $574.01M | N/A | 161.13% | 93.89% | 96.07% |
| CorMedix Inc. (CRMD)vs › | $566.43M | 40.62% | 9.52% | -25.24% | -32.61% |
| CytomX Therapeutics, Inc. (CTMX)vs › | $562.76M | -26.37% | -3503.18% | -1722.33% | 3198.08% |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| Prime Medicine, Inc. (PRME)vs › | $627.65M | -471.98% | -147.16% | -120.43% | -93.49% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $548.18M | -60.79% | -73.94% | -62.04% | -71.62% |
ROE
-11.6%
ROA
-7.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -11.56% |
| 2026-03-31 | -11.71% |
| 2025-12-31 | -11.44% |
| 2025-09-30 | -13.06% |
| 2025-06-30 | -11.75% |
| 2025-03-31 | -11.72% |
| 2024-12-31 | -10.67% |
| 2024-09-30 | -7.67% |
| 2024-06-30 | -6.76% |
| 2024-03-31 | -5.93% |
| 2023-12-31 | -5.56% |
| 2023-09-30 | -5.91% |
| 2023-06-30 | 0.26% |
| 2023-03-31 | 0.95% |
| 2022-12-31 | 0.33% |
| 2022-09-30 | 2.39% |
| 2022-06-30 | -5.09% |
| 2022-03-31 | -6.97% |
| 2021-12-31 | -7.21% |
| 2021-09-30 | -13.72% |
| 2021-06-30 | -14.75% |
| 2021-03-31 | -17.28% |
| 2020-12-31 | -14.03% |
| 2020-09-30 | -10.17% |
| 2020-06-30 | -9.27% |
| 2020-03-31 | -11.24% |
| 2019-12-31 | -9.65% |
| 2019-09-30 | -12.51% |
| 2019-06-30 | -11.32% |
| 2019-03-31 | -12.55% |
| 2018-12-31 | -14.71% |
| 2018-09-30 | -35.40% |
| 2018-06-30 | -33.46% |
| 2018-03-31 | -28.26% |
| 2017-12-31 | -18.81% |
| 2017-09-30 | -242.72% |
| 2017-03-31 | -119.87% |
| 2016-12-31 | -109.63% |
